Cargando…
5-aza-2’-deoxycytidine (DAC) treatment induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in lung cancer cells
BACKGROUND: MAGE-A10 is a subtype of the Melanoma-associated antigen A (MAGE-A), a class of tumor antigens that are extensively expressed in various histological types of tumors and represents an attractive target for tumor immunotherapy. Epigenetic-modifying drugs can enhance the expression of tumo...
Autores principales: | Li, Zhenhua, Guo, Peng, Guo, Peiyuan, Dong, Keqin, Liu, Fei, Wu, Yunyan, Li, Juan, Shan, Baoen, Sang, Meixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798493/ https://www.ncbi.nlm.nih.gov/pubmed/35117468 http://dx.doi.org/10.21037/tcr.2020.01.10 |
Ejemplares similares
-
Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine
por: Shichijo, Shigeki, et al.
Publicado: (1996) -
MAGE‐A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer
por: Gu, Lina, et al.
Publicado: (2018) -
MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008) -
Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
por: Curioni-Fontecedro, A., et al.
Publicado: (2015) -
Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)